microRNAs involved in Parkinson's disease: A systematic review
- 22 September 2016
- journal article
- review article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 14 (5) , 4015-4022
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 55 references indexed in Scilit:
- miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancerCell Death & Disease, 2013
- Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomesFrontiers in Molecular Neuroscience, 2013
- MicroRNAs in neurodegenerative diseases and their therapeutic potentialPharmacology & Therapeutics, 2012
- MicroRNAs in Parkinson's diseaseJournal of Chemical Neuroanatomy, 2011
- miR-365, a Novel Negative Regulator of Interleukin-6 Gene Expression, Is Cooperatively Regulated by Sp1 and NF-κBJournal of Biological Chemistry, 2011
- Post-transcriptional Regulation of α-Synuclein Expression by mir-7 and mir-153Journal of Biological Chemistry, 2010
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's DiseaseNew England Journal of Medicine, 2009
- Serum Insulin-Like Growth Factor-1 and Nitric Oxide Levels in Parkinson's DiseaseMediators of Inflammation, 2009
- Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expressionProceedings of the National Academy of Sciences, 2008
- Variation in the miRNA-433 Binding Site of FGF20 Confers Risk for Parkinson Disease by Overexpression of α-SynucleinThe American Journal of Human Genetics, 2008